Mohs Micrographic Surgery: Development, Technique, and Applications in Cutaneous Malignancies

Eillen Luisa A. Chen; Divya Srivastava; Rajiv I. Nijhawan

doi:10.1055/s-0038-1642057

Seminars in Plastic Surgery, Table of Contents

Semin Plast Surg 2018; 32(02): 060-068
DOI: 10.1055/s-0038-1642057

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Mohs Micrographic Surgery: Development, Technique, and Applications in Cutaneous Malignancies

Authors

Eillen Luisa A. Chen

¹Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
Divya Srivastava

¹Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
Rajiv I. Nijhawan

¹Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas

Abstract

Mohs micrographic surgery (MMS) is a specialized technique for treating skin malignancies that offers the highest cure rate by allowing histological evaluation of the entire peripheral and deep margins. MMS also maximally preserves as much uninvolved, normal adjacent tissue as possible, allowing for the best cosmetic and functional outcomes. When used for appropriate indications, this technique is also more cost-effective than other treatment modalities. In this article, the authors will discuss the development of MMS, the steps involved in this procedure, and the indications for this technique. They will also review the use of MMS for basal cell carcinoma, squamous cell carcinoma, melanoma in situ, and some less common skin malignancies.

Keywords

Mohs micrographic surgery - Mohs surgery - cutaneous malignancies - skin cancer

Full Text

References

References
1 Tolkachjov SN, Brodland DG, Coldiron BM. , et al. Understanding Mohs micrographic surgery: a review and practical guide for the nondermatologist. Mayo Clin Proc 2017; 92 (08) 1261-1271
2 Stein JM, Hrabovsky S, Schuller DE, Siegle RJ. Mohs micrographic surgery and the otolaryngologist. Am J Otolaryngol 2004; 25 (06) 385-393
3 Dim-Jamora KC, Perone JB. Management of cutaneous tumors with Mohs micrographic surgery. Semin Plast Surg 2008; 22 (04) 247-256
4 Benedetto PX, Poblete-Lopez C. Mohs micrographic surgery technique. Dermatol Clin 2011; 29 (02) 141-151 , vii
5 Wain RA, Tehrani H. Reconstructive outcomes of Mohs surgery compared with conventional excision: a 13-month prospective study. J Plast Reconstr Aesthet Surg 2015; 68 (07) 946-952
6 Wood LD, Ammirati CT. An overview of Mohs micrographic surgery for the treatment of basal cell carcinoma. Dermatol Clin 2011; 29 (02) 153-160 , vii
7 Snow SN, Larson PO, Lucarelli MJ, Lemke BN, Madjar DD. Sebaceous carcinoma of the eyelids treated by Mohs micrographic surgery: report of nine cases with review of the literature. Dermatol Surg 2002; 28 (07) 623-631
8 Seidler AM, Bramlette TB, Washington CV, Szeto H, Chen SC. Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectiveness. Dermatol Surg 2009; 35 (11) 1776-1787
9 Ravitskiy L, Brodland DG, Zitelli JA. Cost analysis: Mohs micrographic surgery. Dermatol Surg 2012; 38 (04) 585-594
10 Bialy TL, Whalen J, Veledar E. , et al. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis. Arch Dermatol 2004; 140 (06) 736-742
11 Rogers HW, Coldiron BM. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol 2009; 61 (01) 96-103
12 Wilson LS, Pregenzer M, Basu R. , et al. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg 2012; 38 (04) 570-584
13 Swanson NA. Mohs surgery. Technique, indications, applications, and the future. Arch Dermatol 1983; 119 (09) 761-773
14 Connolly SM, Baker DR, Coldiron BM. , et al; Ad Hoc Task Force; Ratings Panel. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol 2012; 67 (04) 531-550
15 Wang DM, Morgan FC, Besaw RJ, Schmults CD. An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015. J Am Acad Dermatol 2018; 78 (01) 47-53
16 Trost LB, Bailin PL. History of Mohs surgery. Dermatol Clin 2011; 29 (02) 135-139 , vii
17 Mohs FE. Chemosurgery in Cancer, Gangrene, and Infections. Springfield, IL: Charles C. Thomas; 1956
18 Otley C, Roenigk R. Mohs surgery. In: Bolognia J, Jorizzo J, Rapini R. , eds. Dermatology. 2nd ed. St. Louis, MO: Mosby; 2008: 2269-2279
19 Mohs FE. Origin and progress of Mohs micrographic surgery. In: Snow S, Mikhail G. , eds. Mohs Micrographic Surgery. 2nd ed. Madison, WI: University of Wisconsin Press; 2004: 3-13
20 Mohs FE. Chemosurgery for the microscopically controlled excision of external cancer. Arch Belg Dermatol Syphiligr 1958; 14 (01) 1-13
21 Mohs FE. The preparation of frozen sections for use in the chemosurgical technique for the microscopically controlled excision of cancer. J Lab Clin Med 1948; 33 (03) 392-396
22 Mohs FE. Chemosurgery: a microscopically controlled method of cancer excision. Arch Surg 1941; 42 (02) 279-295
23 Mohs FE. Chemosurgical treatment of carcinoma of the face. Arch Dermatol 1947; 56: 143-156
24 Moha FE. Chemosurgery in cutaneous malignancy. Calif Med 1949; 71 (03) 173-177
25 Mohs FE. The chemosurgical method for the microscopically controlled excision of cutaneous cancer. In: Epstein E. , ed. Skin Surgery. Philadelphia, PA: Lea & Febiger; 1956: 171-189
26 Mohs FE. Cancer of the eyelids. Bull Am Coll Chemosurg 1970; 3: 10-11
27 Tromovitch TA, Stegeman SJ. Microscopically controlled excision of skin tumors. Arch Dermatol 1974; 110 (02) 231-232
28 Nijhawan RI, Lee EH, Nehal KS. Biopsy site selfies--a quality improvement pilot study to assist with correct surgical site identification. Dermatol Surg 2015; 41 (04) 499-504
29 The Joint Commission Universal Protocol. http://www.jointcommision.org/standards_information/up.aspx . Accessed November 28, 2017
30 Stewart JH, Cole GW, Klein JA. Neutralized lidocaine with epinephrine for local anesthesia. J Dermatol Surg Oncol 1989; 15 (10) 1081-1083
31 Stewart JH, Chinn SE, Cole GW, Klein JA. Neutralized lidocaine with epinephrine for local anesthesia--II. J Dermatol Surg Oncol 1990; 16 (09) 842-845
32 Chung VQ, Bernardo L, Jiang SB. Presurgical curettage appropriately reduces the number of Mohs stages by better delineating the subclinical extensions of tumor margins. Dermatol Surg 2005; 31 (9 Pt 1): 1094-1099 , discussion 1100
33 Zalla MJ, Lim KK, Dicaudo DJ, Gagnot MM. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000; 26 (08) 771-784
34 Lee E, Wolverton JE, Somani AKA. A simple, effective analogy to elucidate the Mohs micrographic surgery procedure-the peanut butter cup. JAMA Dermatol 2017; 153 (08) 743-744
35 Cumberland L, Dana A, Liegeois N. Mohs micrographic surgery for the management of nonmelanoma skin cancers. Facial Plast Surg Clin North Am 2009; 17 (03) 325-335
36 Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol 2015; 151 (10) 1081-1086
37 Miller SJ, Alam M, Andersen J. , et al; National Comprehensive Cancer Network. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2007; 5 (05) 506-529
38 Connolly KL, Nehal KS, Disa JJ. Evidence-based medicine: cutaneous facial malignancies: nonmelanoma skin cancer. Plast Reconstr Surg 2017; 139 (01) 181e-190e
39 Smeets NW, Kuijpers DI, Nelemans P. , et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature. Br J Dermatol 2004; 151 (01) 141-147
40 Rowe DE, Carroll RJ, Day Jr CL. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15 (03) 315-328
41 Rowe DE, Carroll RJ, Day Jr CL. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15 (04) 424-431
42 van Loo E, Mosterd K, Krekels GA. , et al. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer 2014; 50 (17) 3011-3020
43 Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol 2005; 53 (02) 261-266
44 Holmkvist KA, Roenigk RK. Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: outcome at 5 years. J Am Acad Dermatol 1998; 38 (6 Pt 1): 960-966
45 Zaiac MN, Weiss E. Mohs micrographic surgery of the nail unit and squamous cell carcinoma. Dermatol Surg 2001; 27 (03) 246-251
46 Mikhail GR. Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol 1980; 6 (12) 1027-1035
47 Mehrany K, Byrd DR, Roenigk RK. , et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg 2003; 29 (02) 129-134
48 Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005; 80 (2, Suppl): S254-S264
49 Upjohn E, Bhore R, Taylor RS. Solid organ transplant recipients presenting for Mohs micrographic surgery: a retrospective case-control study. Dermatol Surg 2012; 38 (09) 1448-1455
50 El Tal AK, Abrou AE, Stiff MA, Mehregan DA. Immunostaining in Mohs micrographic surgery: a review. Dermatol Surg 2010; 36 (03) 275-290
51 Donaldson MR, Deeths MJ, Weber LA. Rapid SOX10 immunostain on fresh frozen tissue. Dermatol Surg 2016; 42 (02) 269-271
52 Etzkorn JR, Sobanko JF, Elenitsas R. , et al. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment. J Am Acad Dermatol 2015; 72 (05) 840-850
53 Chang KH, Finn DT, Lee D, Bhawan J, Dallal GE, Rogers GS. Novel 16-minute technique for evaluating melanoma resection margins during Mohs surgery. J Am Acad Dermatol 2011; 64 (01) 107-112
54 Kimyai-Asadi A, Ayala GB, Goldberg LH, Vujevich J, Jih MH. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections. Dermatol Surg 2008; 34 (04) 498-500
55 Cherpelis BS, Moore R, Ladd S, Chen R, Glass LF. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol. Dermatol Surg 2009; 35 (02) 207-213
56 Kelley LC, Starkus L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J Am Acad Dermatol 2002; 46 (01) 78-84
57 Stigall LE, Brodland DG, Zitelli JA. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities. J Am Acad Dermatol 2016; 75 (05) 1015-1021
58 Felton S, Taylor RS, Srivastava D. Excision margins for melanoma in situ on the head and neck. Dermatol Surg 2016; 42 (03) 327-334
59 Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997; 37 (2 Pt 1): 236-245
60 Davis JL, Randle HW, Zalla MJ, Roenigk RK, Brodland DG. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. Dermatol Surg 1997; 23 (02) 105-110
61 Lowe GC, Onajin O, Baum CL. , et al. A comparison of Mohs micrographic surgery and wide local excision for treatment of dermatofibrosarcoma protuberans with long-term follow-up: the Mayo Clinic experience. Dermatol Surg 2017; 43 (01) 98-106
62 O'Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997; 23 (10) 929-933
63 Leibovitch I, Huilgol SC, Selva D, Lun K, Richards S, Paver R. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. J Am Acad Dermatol 2005; 52 (02) 295-300
64 Spencer JM, Nossa R, Tse DT, Sequeira M. Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery. J Am Acad Dermatol 2001; 44 (06) 1004-1009
65 Song SS, Wu Lee W, Hamman MS, Jiang SI. Mohs micrographic surgery for eccrine porocarcinoma: an update and review of the literature. Dermatol Surg 2015; 41 (03) 301-306
66 Humphreys TR, Finkelstein DH, Lee JB. Superficial leiomyosarcoma treated with Mohs micrographic surgery. Dermatol Surg 2004; 30 (01) 108-112
67 Bae JM, Choi YY, Kim H. , et al. Mohs micrographic surgery for extramammary Paget disease: a pooled analysis of individual patient data. J Am Acad Dermatol 2013; 68 (04) 632-637
68 Knackstedt RW, Knackstedt TJ, Findley AB. , et al. Aggressive digital papillary adenocarcinoma: treatment with Mohs micrographic surgery and an update of the literature. Int J Dermatol 2017; 56 (10) 1061-1064
69 Haynes D, Thompson C, Leitenberger J, Vetto J. Mohs micrographic surgery as a digit-sparing treatment for aggressive digital papillary adenocarcinoma. Dermatol Surg 2017
70 Tran AN, Boyer JD. Phaeohyphomycosis of the hand treated using Mohs micrographic surgery. Dermatol Surg 2013; 39 (08) 1276-1279
71 Withers AH, Brougham ND, Barber RM, Tan ST. Atypical fibroxanthoma and malignant fibrous histiocytoma. J Plast Reconstr Aesthet Surg 2011; 64 (11) e273-e278
72 Mahalingam S, Shah A, Stewart A. Atypical Fibroxanthoma: a case series and review of literature. Auris Nasus Larynx 2015; 42 (06) 469-471
73 Zalla MJ, Randle HW, Brodland DG, Davis JL, Roenigk RK. Mohs surgery vs wide excision for atypical fibroxanthoma: follow-up. Dermatol Surg 1997; 23 (12) 1223-1224
74 Ang GC, Roenigk RK, Otley CC, Kim Phillips P, Weaver AL. More than 2 decades of treating atypical fibroxanthoma at Mayo Clinic: what have we learned from 91 patients?. Dermatol Surg 2009; 35 (05) 765-772
75 Huether MJ, Zitelli JA, Brodland DG. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 2001; 44 (04) 656-659
76 Foroozan M, Sei JF, Amini M, Beauchet A, Saiag P. Efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: systematic review. Arch Dermatol 2012; 148 (09) 1055-1063
77 Gloster Jr HM, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996; 35 (01) 82-87
78 Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML, Sable DB. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer 2004; 101 (01) 28-38
79 Gollard R, Weber R, Kosty MP, Greenway HT, Massullo V, Humberson C. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer 2000; 88 (08) 1842-1851
80 Boyer JD, Zitelli JA, Brodland DG, D'Angelo G. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002; 47 (06) 885-892
81 Tarantola TI, Vallow LA, Halyard MY. , et al. Prognostic factors in Merkel cell carcinoma: analysis of 240 cases. J Am Acad Dermatol 2013; 68 (03) 425-432
82 Santamaria-Barria JA, Boland GM, Yeap BY, Nardi V, Dias-Santagata D, Cusack Jr JC. Merkel cell carcinoma: 30-year experience from a single institution. Ann Surg Oncol 2013; 20 (04) 1365-1373
83 Lewis KG, Weinstock MA, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 2006; 142 (06) 693-700
84 Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol 2007; 25 (09) 1043-1047
85 Chiller K, Passaro D, Scheuller M, Singer M, McCalmont T, Grekin RC. Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome. Arch Dermatol 2000; 136 (11) 1355-1359
86 Hamm JC, Argenta LC, Swanson NA. Microcystic adnexal carcinoma: an unpredictable aggressive neoplasm. Ann Plast Surg 1987; 19 (02) 173-180
87 Friedman PM, Friedman RH, Jiang SB, Nouri K, Amonette R, Robins P. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol 1999; 41 (2 Pt 1): 225-231
88 Abbate M, Zeitouni NC, Seyler M, Hicks W, Loree T, Cheney RT. Clinical course, risk factors, and treatment of microcystic adnexal carcinoma: a short series report. Dermatol Surg 2003; 29 (10) 1035-1038
89 Snow S, Madjar DD, Hardy S. , et al. Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg 2001; 27 (04) 401-408
90 Burns MK, Chen SP, Goldberg LH. Microcystic adnexal carcinoma. Ten cases treated by Mohs micrographic surgery. J Dermatol Surg Oncol 1994; 20 (07) 429-434
91 Kyllo RL, Brady KL, Hurst EA. Sebaceous carcinoma: review of the literature. Dermatol Surg 2015; 41 (01) 1-15
92 Ratz JL, Luu-Duong S, Kulwin DR. Sebaceous carcinoma of the eyelid treated with Mohs' surgery. J Am Acad Dermatol 1986; 14 (04) 668-673